Silence Therapeutics plc (SLN) [Rocket]

Overview

Silence Therapeutics plc (SLN)

Add to portfolio

1m \| 3m \| 6m \| 1y \| 2y \| 5y \| 10y

Price:	$121.50			Metrics
OS:	107.8	M
Market cap:	$13.1	B
Net cash:	$27.4	M		$0.25	per share
EV:	$13.1	B

TTM Valuation
EBITDA
EBIT
EPS

Recent News + Filings (All items)

Date Filed	Type	Description
08/16/2023	6-K	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
08/14/2023	SC 13D/A	Griffiths Richard Ian reports a 26.6% stake in Silence Therapeutics plc
08/01/2023	S-8	Form S-8 - Securities to be offered to employees in employee benefit plans:
07/11/2023	6-K	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
07/03/2023	6-K	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
05/04/2023	6-K	Quarterly results
05/01/2023	6-K	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

Revenue Mix by Segment

Financial Summary (All financials)

In millions, except per share items	Dec-31-20	Dec-31-19	Dec-31-18


EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy